Corticotropin-releasing factor: Effect on cerebral blood flow in physiologic and ischaemic conditions

Experimental Brain Research

Volumn 165, Issue 3, 2005, Pages 375-382

  De Michele, Manuela ^a,e   Touzani, Omar ^b,e   Foster, Alan C ^c   Fieschi, Cesare ^a   Sette, Giuliano ^a   McCulloch, James ^d,e  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITÉ DE CAEN   (France)

^c NEUROCRINE BIOSCIENCES INC   (United States)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cerebral infarction; Corticotropin releasing hormone; Laser Doppler flowmetry; Middle cerebral artery; Rats

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR DERIVATIVE; SAUVAGINE; UROCORTIN;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSISTED VENTILATION; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; LASER DOPPLER FLOWMETRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOLECULAR PROBE; NONHUMAN; PEPTIDERGIC NERVOUS SYSTEM; PRIORITY JOURNAL; RAT; SUBARACHNOID SPACE; TACHYPHYLAXIS; VASODILATATION;

ANIMALS; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; CORTICOTROPIN-RELEASING HORMONE; ENDOTHELIN-1; IMMUNOHISTOCHEMISTRY; INJECTIONS; MALE; MIDDLE CEREBRAL ARTERY; NEUROPEPTIDES; RATS; RATS, INBRED F344; SUBARACHNOID SPACE;

EID: 23944467512     PISSN: 00144819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00221-005-2303-0     Document Type: Article

References (22)

1. Al-Noaemi MC, Edwarson JA, Hughes D (1982) Corticotropin-releasing factor (CRF) stimulates release of peptides from the intermediate lobe of the rat pituitary gland. J Physiol 332:85-86
2. Behan DP, Khongsaly O, Ling N, De Souza EB (1996) Urocortin interaction with corticotropin-releasing factor (CRF) binding protein (CRF-BP): a novel mechanism for elevating "free" CRF levels in human brain. Brain Res 725(2):263-267
3. Chalmers DT, Lovenberg TW, De Souza EB (1995) Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 15(10):6340-6350
4. Chalmers DT, Lovenberg TW, Grigoriadis DE, Behan DP, De Souza EB (1996) Corticotropin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol Sci 17:166-172
5. Dautzenberg FM, Hauger RL (2002) The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci 23(2):71-77
6. Dawson DA, Hallenbeck JM (1996) Acute focal ischemia-induced alterations in MAP2 immunostaining: description of temporal changes and utilization as a marker for volumetric assessment of acute brain injury. J Cereb Blood Flow Metab 16(1):170-174
7. Dieterich KD, Lehnert H, De Souza EB (1997) Corticotropin-releasing factor receptors: an overview. Exp Clin Endocrinol Diabetes 105(2):65-82
8. Latchman DS (2002) Urocortin. Int J Biochem Cell Biol 34(8):907-910
9. Lei S, Richter R, Bienert M, Mulvany MJ (1993) Relaxing actions of corticotropin-releasing factor on rat resistance arteries. Br J Pharmacol 108: 941-947
10. Lenz HJ, Fisher LA, Vale WW, Brown MR (1985) Corticotropin-releasing factor, sauvagine and urotensin I: effect on blood flow. Am J Physiol 249:R85-R90
11. Lyons MK, Anderson RE, Meyer FB (1991) Corticotropin-releasing factor antagonist reduces ischemic hippocampal neuronal injury. Brain Res 545:339-342
12. Mackay KB, Bozigian H, Grigoriadis DE, Loddick SA, Verge G, Foster AC (2001) Neuroprotective effects of the CRF1 antagonist R121920 after permanent focal ischemia in the rat. J Cereb Flow Metab 21(10):1208-1214
13. Schilling L, Kanzler C, Schmiedek P, Ehrenreich H (1998) Characterization of the relaxant action of urocortin, a new peptide related to corticotropin-releasing factor in the rat isolated basilar artery. Br J Pharmacol 125(6):1164-1171
14. Seasholtz AF, Valverde RA, Denver RJ (2002) Corticotropin-releasing hormone-binding protein: biochemistry and function from fish to mammals. J Endocrinol 175(1):89-97
15. Schumann P, Touzani O, Young AR, Baron JC, MacKenzie ET (1996) The relationship between cerebral blood flow (CBF) and cerebral blood volume (CBV) in the primate: the CBF/CBV ratio as an index of cerebral perfusion pressure? In: Krieglstein J (ed) Pharmacology of cerebral ischemia. Medpharm Sci. Publ., Stuttgart, Germany, pp 301-314
16. Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M (1977) The [14C]deoxy glucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28(5):897-916
17. Stevens SL, Shaw TE, Dykhuizen E, Lessov NS, Hill JK, Wurst W, Stenzel-Poore MP (2003) Reduced cerebral injury in CRH-R1 deficient mice after focal ischemia: a potential link to microglia and atrocytes that express CRH-R1. J Cereb Blood Flow Metab 23(10):1151-1159
18. Strijbos PJLM, Renton JK, Rotwell NJ (1994) Corticotropin-releasing factor antagonist inhibits neuronal damage induced by focal cerebral ischemia or activation of NMDA receptors in the rat brain. Brain Res 65:405-408
19. Tamura A, Graham DI, McCulloch J, Teasdale GM (1981) Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1:53-60
20. Wong ML, Loddick SA, Bongiorno PB, Gold PW, Rotwell NJ, Lucinio J (1995) Corticotropin-releasing hormone (CRH) mRNA is rapidly induced in rat cerebral cortex and amygdala during focal cerebral ischemia. NeuroReport 6:1785-1788
21. Yatsushiro K, Chalmers DT, De Souza EB, McCulloch J (1997a) The presence and vasomotor significance of corticotrophin-releasing factor subtypes in feline cerebral arterioles. J Cereb Blood Flow Metab 17(Suppl 1):S287
22. Yatsushiro K, Chalmers DT, Loddick SA, De Souza EB, Graham DI, McCulloch J (1997b) The involvement of corticotrophin releasing factor (CRF) in focal cerebral ischaemia. J Cereb Blood Flow Metab 17(Suppl 1):S533